Related Experiment Video
Updated: Nov 5, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Improving adherence to daily preexposure prophylaxis among MSM in Amsterdam by providing feedback via a mobile
Mark A M van den Elshout1, Elske Hoornenborg1, Roel C A Achterbergh1
1Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
Objective:
Improving adherence to preexposure prophylaxis (PrEP) by providing automated feedback on self-reported PrEP use via a mobile application (app).
Design:
Randomized clinical trial among MSM participating in the Amsterdam PrEP demonstration project (AMPrEP).
Methods:
Eligible participants were randomized 1 : 1 to the control or intervention app. Both allowed daily reporting of sexual behaviour and medication intake; the intervention app also provided visual feedback. Dried blood spots collected at 12 and 24 months yielded intracellular tenofovir diphosphate concentrations (TFV-DP). We assessed proportions of participants with poor (TFV-DP <700 fmol/punch; primary outcome), good (TFV-DP ≥700 fmol/punch) and excellent (TFV-DP ≥1250 fmol/punch; secondary outcome) adherence at both time-points, and the association with the control or intervention app.
Results:
We randomized 229 participants, 118 to the intervention and 111 to the control arm. The primary, per-protocol, analysis included 83 participants per arm. In total, 22/166 (13%) of participants adhered poorly, 144/166 (87%) good and 66/166 (40%) excellently. App feedback did not result in a lower proportion of participants with poor adherence [control: 9 of 83 (11%); intervention: 13 of 83 (16%); P = 0.36]. App feedback did result in a larger proportion of participants with excellent adherence [control: 26/83 (31%); intervention: 40/83 (48%); P = 0.026].
Conclusion:
In this highly adherent population, app feedback did not improve the proportion of participants with poor adherence to PrEP.Clinical Trial Number Netherlands Trial Register: NL5413.
Insights
Mobile app feedback did not improve pre-exposure prophylaxis (PrEP) adherence in a highly adherent group. However, it did increase excellent adherence rates among participants in the Amsterdam PrEP demonstration project.
Area of Science:
- Public Health
- Infectious Disease Prevention
- Digital Health Interventions
Background:
- Pre-exposure prophylaxis (PrEP) is a key strategy for HIV prevention.
- Adherence to PrEP is crucial for its effectiveness.
- Mobile applications offer potential for monitoring and improving adherence.
Purpose of the Study:
- To evaluate the impact of automated mobile app feedback on PrEP adherence.
- To assess the effect of visual feedback on self-reported PrEP use and adherence levels.
Main Methods:
- A randomized clinical trial was conducted among men who have sex with men (MSM) in the Amsterdam PrEP demonstration project (AMPrEP).
- Participants were randomized to a control or intervention app group, both allowing daily reporting.
- Intracellular tenofovir diphosphate (TFV-DP) concentrations in dried blood spots were used to measure adherence at 12 and 24 months.
Main Results:
- Overall, 13% of participants showed poor adherence, 87% good adherence, and 40% excellent adherence.
- The intervention app did not significantly reduce the proportion of participants with poor adherence (16% vs. 11%, P=0.36).
- The intervention app significantly increased the proportion of participants with excellent adherence (48% vs. 31%, P=0.026).
Conclusions:
- Automated mobile app feedback did not improve poor adherence to PrEP in a highly adherent population.
- The intervention showed a positive effect on achieving excellent adherence levels.
- Further research may explore tailored feedback mechanisms for diverse adherence profiles.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Drug Therapy
Antianxiety Medications
Sexually Transmitted Infections

